With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.

They’re expensive and aren’t a short-term fix, but Ozempic and Wegovy show great promise in regulating weight. | Opinion ...

Needless to say, because this is an experimental and unauthorized approach, there are no microdosing guidelines. There is also no reliable information about the safety of this practice, or the ...

While appearing on the March 13 episode of Grindr's Who's the A------ podcast, the Hacks star, 34, spoke about a host of ...

Still, since Ozempic was approved in 2017, thousands of studies have been published examining the effects of GLP-1s. Last ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.

Weight loss drugs like Ozempic deliver more health benefits than expected.